Most of the compounds exhibited strong antiproliferation activity against the tested gastric carcinoma cell lines (HGC27, MKN28, AZ521, AGS, and MKN1), which were more potent than the positive controls cisplatin and C188-9. This evidence concerns the gene JAG1 and gastric carcinoma.